Stage IB Cervical Cancer: Clinical Trials

2 trials for Stage IB Cervical Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Terminated 2

Follow Stage IB Cervical Cancer: new trials by email Literature Review of Stage IB Cervical Cancer trials Research Report on Stage IB Cervical Cancer

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer
Management of Therapy Complications, Quality-of-Life Assessment - Lymphedema, Stage 0 Cervical Cancer
Phase 3TerminatedGynecologic Oncology Group22007-12-012021-06-23
Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
cisplatin, tirapazamine - Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma
Phase 3TerminatedNational Cancer Institute (NCI)4022006-02-012019-07-23

Narrower conditions

Uterine Cervical Neoplasms (2)  ·  Lymphedema (1)  ·  Uterine Cervical Dysplasia (1)  ·  Vulvar Neoplasms (1)

Broader conditions

Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Genital Neoplasms, Female (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Urogenital Diseases (2)  ·  Urogenital Neoplasms (2)  ·  Uterine Cervical Diseases (2)  ·  Uterine Diseases (2)  ·  Uterine Neoplasms (2)  ·  Hemic and Lymphatic Diseases (1)  ·  Lymphatic Diseases (1)  ·  Precancerous Conditions (1)

Interventions

Cisplatin (1)  ·  Tirapazamine (1)

Sponsors

Gynecologic Oncology Group (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Levi Downs (1)  ·  Paul DiSilvestro (1)

Results publications

PMID 24395863

NIH funding

U10CA027469 (1), U10CA101165 (1)